| Tania H Hall, MD | |
|
3260 Providence Dr, Ste 322, Anchorage, AK 99508-4661 | |
| (907) 563-5151 | |
| (907) 563-6278 |
| Full Name | Tania H Hall |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 12 Years |
| Location | 3260 Providence Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073809547 | NPI | - | NPPES |
| 1631642 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 100798 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Womens Health Pc | 7012090210 | 11 |
News Archive
The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.
Speaking at a briefing on Tuesday at the Center for Strategic and International Studies in Washington, D.C., Deputy Global AIDS Coordinator Julia Martin said "[t]he decision about whether to reauthorize [PEPFAR] 'rests with Congress. ... Whether we move in that direction is yet to be fully determined but PEPFAR will continue at the will of Congress,'" CQ HealthBeat reports.
The findings of a scientific conference examining the growing body of research and potential health benefits of S-equol were published this month in the Journal of Nutrition. Manuscripts based on presentations made at the conference, which was organized by the Life Sciences Research Office, reveal data that S-equol is a safe, natural and effective solution to providing relief of menopausal symptoms such as hot flashes and muscle discomfort.
A technique that removes additional toxins during dialysis does not improve kidney failure patients' survival or heart health, but intense treatments may provide a benefit, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 5 days ago
| Entity Name | Anchorage Women's Clinic At Providence Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265496061 PECOS PAC ID: 9032102124 Enrollment ID: O20040405001651 |
News Archive
The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.
Speaking at a briefing on Tuesday at the Center for Strategic and International Studies in Washington, D.C., Deputy Global AIDS Coordinator Julia Martin said "[t]he decision about whether to reauthorize [PEPFAR] 'rests with Congress. ... Whether we move in that direction is yet to be fully determined but PEPFAR will continue at the will of Congress,'" CQ HealthBeat reports.
The findings of a scientific conference examining the growing body of research and potential health benefits of S-equol were published this month in the Journal of Nutrition. Manuscripts based on presentations made at the conference, which was organized by the Life Sciences Research Office, reveal data that S-equol is a safe, natural and effective solution to providing relief of menopausal symptoms such as hot flashes and muscle discomfort.
A technique that removes additional toxins during dialysis does not improve kidney failure patients' survival or heart health, but intense treatments may provide a benefit, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 5 days ago
| Entity Name | Alaska Womens Health Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083890180 PECOS PAC ID: 7012090210 Enrollment ID: O20080212000034 |
News Archive
The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.
Speaking at a briefing on Tuesday at the Center for Strategic and International Studies in Washington, D.C., Deputy Global AIDS Coordinator Julia Martin said "[t]he decision about whether to reauthorize [PEPFAR] 'rests with Congress. ... Whether we move in that direction is yet to be fully determined but PEPFAR will continue at the will of Congress,'" CQ HealthBeat reports.
The findings of a scientific conference examining the growing body of research and potential health benefits of S-equol were published this month in the Journal of Nutrition. Manuscripts based on presentations made at the conference, which was organized by the Life Sciences Research Office, reveal data that S-equol is a safe, natural and effective solution to providing relief of menopausal symptoms such as hot flashes and muscle discomfort.
A technique that removes additional toxins during dialysis does not improve kidney failure patients' survival or heart health, but intense treatments may provide a benefit, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 5 days ago
| Entity Name | Obhg Alaska Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740697069 PECOS PAC ID: 7113233834 Enrollment ID: O20150826000621 |
News Archive
The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.
Speaking at a briefing on Tuesday at the Center for Strategic and International Studies in Washington, D.C., Deputy Global AIDS Coordinator Julia Martin said "[t]he decision about whether to reauthorize [PEPFAR] 'rests with Congress. ... Whether we move in that direction is yet to be fully determined but PEPFAR will continue at the will of Congress,'" CQ HealthBeat reports.
The findings of a scientific conference examining the growing body of research and potential health benefits of S-equol were published this month in the Journal of Nutrition. Manuscripts based on presentations made at the conference, which was organized by the Life Sciences Research Office, reveal data that S-equol is a safe, natural and effective solution to providing relief of menopausal symptoms such as hot flashes and muscle discomfort.
A technique that removes additional toxins during dialysis does not improve kidney failure patients' survival or heart health, but intense treatments may provide a benefit, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tania H Hall, MD 3260 Providence Dr, Ste 322, Anchorage, AK 99508-4661 Ph: (907) 563-5151 | Tania H Hall, MD 3260 Providence Dr, Ste 322, Anchorage, AK 99508-4661 Ph: (907) 563-5151 |
News Archive
The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.
Speaking at a briefing on Tuesday at the Center for Strategic and International Studies in Washington, D.C., Deputy Global AIDS Coordinator Julia Martin said "[t]he decision about whether to reauthorize [PEPFAR] 'rests with Congress. ... Whether we move in that direction is yet to be fully determined but PEPFAR will continue at the will of Congress,'" CQ HealthBeat reports.
The findings of a scientific conference examining the growing body of research and potential health benefits of S-equol were published this month in the Journal of Nutrition. Manuscripts based on presentations made at the conference, which was organized by the Life Sciences Research Office, reveal data that S-equol is a safe, natural and effective solution to providing relief of menopausal symptoms such as hot flashes and muscle discomfort.
A technique that removes additional toxins during dialysis does not improve kidney failure patients' survival or heart health, but intense treatments may provide a benefit, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 5 days ago
Dr. Wendy Sue Cruz, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2741 Debarr Rd Ste C205, Anchorage, AK 99508 Phone: 907-279-2273 Fax: 907-258-7705 | |
Dr. James Thomas Barber Jr., D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3831 Piper St Ste Sll020, Anchorage, AK 99508 Phone: 907-212-3470 Fax: 907-212-3474 | |
Dr. Natalie Dawn Ward, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3260 Providence Dr, Ste. #425, Anchorage, AK 99508 Phone: 907-561-7111 Fax: 907-770-7891 | |
Mrs. Kristin M Murray, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4115 Lake Otis Pkwy, Anchorage, AK 99508 Phone: 907-563-7228 Fax: 907-563-6278 | |
Kathryn Murphy, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4320 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-3116 | |
Dr. Sylvia Moses, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3260 Providence Dr Ste 322, Anchorage, AK 99508 Phone: 907-563-7228 |